Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Targetome

Targetome
2010 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
$998K LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of affinity-based targeted therapies intended to be used for the diagnosis of cancer. The company's therapies works with the help of a biomarker discovery platform, enabling healthcare professionals to get the treatment of pancreatic cancer or liver metastases along with getting services related to the identification and validation of proteomic biomarkers and biologics generation, for the therapeutic or diagnostic purpose.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Pharmaceuticals and Biotechnology
Other Healthcare Services
Primary Office
  • GIGA EE1 Tower
  • Avenue Hippocrate 5
  • 4000 Liège
  • Belgium

+32 04 000 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Targetome’s full profile, request a free trial.

Targetome Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 29-Feb-2016 $998K 00.000 Completed Generating Revenue
3. Early Stage VC 09-Oct-2015 00000 00.000 00.000 Completed Generating Revenue
2. Early Stage VC 26-Jul-2013 $1.08M $1.08M 00.000 Completed Startup
1. Accelerator/Incubator 01-Sep-2011 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Targetome Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Class G 0,000 0000.00 0000.00 00 0000.00 00.000
Class F 000 0000.00 0000.00 00 0000.00 00.000
Class C 000 0000.00 0000.00 00 0000.00 0.000
Preference 2,252 $336.88 $336.88 1x $336.88 40.02%
Preference 500 $336.88 $336.88 1x $336.88 8.89%
To view this company’s complete Cap Table, request access »

Targetome Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Walloon Region Lender/Debt Provider 000 0000 000000 0
Medical Research Council Technology Corporation Minority 000 0000 000000 0
Gesval Lender/Debt Provider Minority 000 0000 000000 0
Noshaq Venture Capital Minority 000 0000 000000 0
WBC Accelerator/Incubator Minority 000 0000 000000 0

Targetome Executive Team (2)

Name Title Board
Seat
Contact
Info
Vincent Castronovo Founder

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »